# Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension

> **NCT02973035** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 104 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Amlodipine
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT02973035
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2020-01-06
- **Final completion:** 2020-01-06
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2020-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973035, "Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02973035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*